Insider Trading History of Bolzon Bradley J Phd


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bolzon Bradley J Phd since year 2005. The trader's CIK number is 1354345. At the time of the last reporting, Bolzon Bradley J Phd was the Director of Black Diamond Therapeutics, Inc. . (stock ticker symbol BDTX). See this page for all insider trading activities at Black Diamond Therapeutics, Inc. .

Note that in the past Bolzon Bradley J PhD also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Bolzon Bradley J Phd since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-02-03 BDTX Black Diamond Therapeutics, Inc. Buy 894,736 19.00 16,999,984
2019-11-19 CRSP Crispr Therapeutics Ag Sale 42,000 67.41 2,831,388
2019-10-30 CRSP Crispr Therapeutics Ag Sale 21,000 51.89 1,089,669
2018-05-15 CRSP Crispr Therapeutics Ag Sale 44,000 58.35 2,567,400
2018-05-07 CRSP Crispr Therapeutics Ag Sale 119,709 50.78 6,079,421
2018-05-08 CRSP Crispr Therapeutics Ag Sale 9,241 50.77 469,165
2018-04-30 CRSP Crispr Therapeutics Ag Sale 30,566 50.28 1,536,950
2018-04-26 CRSP Crispr Therapeutics Ag Sale 210,610 50.12 10,554,720
2018-04-27 CRSP Crispr Therapeutics Ag Sale 11,648 50.03 582,807
2018-04-24 CRSP Crispr Therapeutics Ag Sale 22,841 50.90 1,162,606
2018-04-23 CRSP Crispr Therapeutics Ag Sale 101,994 50.83 5,184,355
2017-12-22 CRSP Crispr Therapeutics Ag Sale 26,016 20.30 528,228
2017-11-24 CRSP Crispr Therapeutics Ag Sale 1,507 20.21 30,450
2017-11-27 CRSP Crispr Therapeutics Ag Sale 200 20.24 4,047
2016-10-24 CRSP Crispr Therapeutics Ag Buy 161,000 14.00 2,254,000
2016-05-23 PZRX Phaserx, Inc. Buy 600,000 5.00 3,000,000
2016-05-23 PZRX Phaserx, Inc. Sale 258,044 .01 2,580
2014-02-18 FLXN Flexion Therapeutics Inc Buy 307,692 13.00 3,999,996
2006-05-15 NOVC Paratek Pharmaceuticals, Inc. Buy 230,769 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bolzon Bradley J Phd (Director of Black Diamond Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month